PVG Amends Proxy, Reveals $400K Solicitation Budget and Full Trading History in Anavex Board Fight
AVXL sits 50% above its 52-week low of $2.255 on elevated volume (2.1× avg).
Summary
PVG Asset Management filed an amended proxy in its fight to replace Anavex's board, disclosing a $400,000 solicitation budget, a $110,000 fee to proxy solicitor InvestorCom, and a full two-year trading history showing a net 331,903-share position in custodial accounts.
Key Events · Executive and Board Changes · AVXL
-
PVG Discloses Full Trading History
Schedule I reveals PVG's custodial accounts made a net purchase of 331,903 shares over the past two years, while PVG Asset Management itself holds a net 5,760 shares, for a combined 337,663 shares (0.36% of outstanding).
-
Solicitation Budget Set at $400K
PVG estimates total proxy solicitation costs at $400,000, with approximately $75,000 already incurred, and will pay InvestorCom LLC a fee of no more than $110,000 plus expenses.
-
PVG to Seek Reimbursement
If successful in electing its nominees, PVG intends to seek reimbursement of solicitation expenses from Anavex without submitting the question to a stockholder vote.
-
Annual Meeting Set for September 24
The contested election will be held virtually on September 24, 2026, with a record date of July 31, 2026, and 92,696,842 shares outstanding and entitled to vote.
Analysis · AVXL · Life Sciences
PVG Asset Management's latest amended proxy adds new material details to the ongoing board contest: a complete two-year transaction history showing it accumulated a net 331,903 shares through custodial accounts, and a solicitation budget of $400,000 with a $110,000 fee to proxy solicitor InvestorCom. The filing also confirms PVG will seek reimbursement from Anavex if successful, a cost the company would bear. The September 24 annual meeting is now less than a month away, and the filing sharpens the picture of PVG's financial commitment and its stake — 337,663 shares, or about 0.36% of the 92.7 million shares outstanding. The contest itself is well known, but the new cost and trading disclosures give stockholders concrete data on the activist's skin in the game and the expense of the fight.
How filings like this one have moved
In the 30 days to Aug 27, 2026, 29% of the 2915 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AVXL was trading at $3.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $330M. The 52-week trading range was $2.26 to $10.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.